Associations among processes and outcomes of care for Medicare nursing home residents with acute heart failure.
OBJECTIVE
To characterize Medicare skilled nursing facility (SNF) residents who become acutely ill with heart failure (HF) and assess the association between the outcomes of rehospitalization and mortality, and severity of the acute exacerbation, comorbidity, and processes of care.


METHODS
SNF medical record review of Medicare patients who developed an acute exacerbation of heart failure (HF) during the 90 days following nursing home admission.


METHODS
A total of 58 SNFs in 5 states during 1994 and 1997.


METHODS
Patients with 156 episodes of acute HF among 4693 random Medicare nursing home admissions.


METHODS
Demographic variables, symptoms, signs, comorbidity, nursing home characteristics, nurse staffing ratios, and processes of care were compared between acute HF subjects transferred to hospital and those not transferred; and between subjects who died within 30 days of an acute exacerbation and those who survived.


RESULTS
After adjusting for age, disease severity, and comorbidity, residents whose change in condition was evaluated during the night shift were more likely to be hospitalized (OR 4.20, 95%CI 1.01-17.50). Residents who were prescribed an angiotensin-converting enzyme inhibitor or who received an order for skilled nursing observation more often than once a shift were 1/3 as likely to die as those who did not (OR 0.303, 95%CI 0.11-0.82), after adjusting for hypotension, delirium, do not resuscitate orders, and prior hospital length of stay.


CONCLUSIONS
For residents who develop an acute exacerbation of HF during a SNF stay, there is an association between attributes of nursing home care and the outcomes of rehospitalization and mortality.
Hutt
Evelyn
E
Division of Health Care Policy and Research, University of Colorado Health Sciences Center, Denver, 80206, USA. Evelyn.Hutt@uchsc.edu
Frederickson
Elizabeth
E
Ecord
Mary
M
Kramer
Andrew M
AM
D000208:Acute Disease; D000368:Aged; D000369:Aged, 80 and over; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D015897:Comorbidity; D003693:Delirium / Q000150:complications; D017050:Episode of Care; D005260:Female; D006302:Health Services Research; D006333:Heart Failure / Q000150:complications / Q000401:mortality* / Q000628:therapy; D006801:Humans; D007902:Length of Stay / Q000706:statistics & numerical data; D008297:Male; D006278:Medicare / Q000592:standards*; D009551:Night Care / Q000592:standards; D009730:Nursing Assessment / Q000592:standards; D010043:Outcome and Process Assessment, Health Care / Q000458:organization & administration*; D010359:Patient Readmission / Q000706:statistics & numerical data*; D010360:Patient Transfer / Q000706:statistics & numerical data; D016414:Resuscitation Orders; D012307:Risk Factors; D012866:Skilled Nursing Facilities / Q000592:standards*; D016019:Survival Analysis; D013997:Time Factors; D014481:United States / Q000453:epidemiology
D000806:Angiotensin-Converting Enzyme Inhibitors